Document is current
Any future updates will be listed below
-
Authors
Badani, Aarav
Ozair, Ahmad
Khasraw, Mustafa
Woodworth, Graeme F.
Tiwari, Pallavi
Ahluwalia, Manmeet S.
Mansouri, Alireza
- License Information
-
More Information
Article History
Received: 21 September 2024
Accepted: 4 November 2024
First Online: 21 November 2024
Declarations
:
: Manmeet Singh Ahluwalia: Grants from Seagen and NIH. Consultation fees from Bayer, Kiyatec, Insightec, GSK, Xoft, Nuvation, SDP Oncology, Apollomics, Prelude, Janssen, Voyager Therapeutics, Viewray, CarisLifesciences, Pyramid Biosciences, Varian Medical Systems, Cairn Therapeutics, AnheartTherapeutics, Theraguix, MenariniRicerche, Sumitomo Pharma Oncology, Autem therapeutics, GT Medical Technologies, Allovir, EquilliumBio., QV Bioelectronics. Scientific Advisory Boardmemberships in Modifibiosciences., Bugworks. DSMC membership for VBI Vaccines. Stockshareholder in: Mimivax, Cytodyn, MedInnovateAdvisors LLC, TrisalusLifesciences. Graeme Woodworth: Grants from Focused Ultrasound Foundation, NIH, Maryland StemCenter Research Foundation. Clinical Trial Support from Insightec and Keep PunchingFoundation. Mustafa Khasraw: Grants or contracts from BMS, AbbVie, BioNTech, CNS Pharmaceuticals, Daiichi Sankyo, Inc., Immorna Therapeutics, Immvira Therapeutics, JAX lab for genomic research, and Personalis, Inc.; received consulting fees from AnHeart Therapeutics, George Clinical, Manarini Stemline, and Servier; received honoraria from GSK; and is on a data safety monitoring board for BPG Bio. All other authors have no disclosures.
